Kimberly Kraig Thompson - 01 Jun 2021 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Role
CEO & CFO, Director, 10%+ Owner
Signature
/s/ Kim Thompson
Issuer symbol
KBLB
Transactions as of
01 Jun 2021
Transactions value $
$0
Form type
4
Date filed
02 Jun 2021, 16:30
Previous filing
26 May 2021
Next filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KBLB Common Stock Sale -60K -0.03% 204M 01 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 60,000 shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on June 1, 2021 at a price of $0.1305 per share.
F2 Includes 204,292,882 shares of common stock that are owned by Mr. Thompson and 2 shares of common stock that may be issued upon conversion of the Series A Preferred Stock that are owned by Mr. Thompson.